The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 3, p. n/a, doi. 10.1111/1755-5922.12254
- By:
- Publication type:
- Article
Works matching IS 17555914 AND DT 2017 AND VI 35 AND IP 3
Results: 12
1
2
Enhanced mRNA expression of plasminogen activator inhibitor-1 in livedoid vasculopathy lesions.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 3, p. n/a, doi. 10.1111/1755-5922.12255
- By:
- Publication type:
- Article
3
Percutaneous coronary intervention vs coronary artery bypass grafting for left main coronary artery disease? A systematic review and meta-analysis of randomized controlled trials.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 3, p. n/a, doi. 10.1111/1755-5922.12260
- By:
- Publication type:
- Article
4
Effect of postprocedural full-dose infusion of bivalirudin on acute stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcomes in a large real-world population.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 3, p. n/a, doi. 10.1111/1755-5922.12251
- By:
- Publication type:
- Article
5
The significance of the washout period in preconditioning.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 3, p. n/a, doi. 10.1111/1755-5922.12252
- By:
- Publication type:
- Article
6
Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
7
Epigenetic regulation in monocyte/macrophage: A key player during atherosclerosis.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 3, p. n/a, doi. 10.1111/1755-5922.12262
- By:
- Publication type:
- Article
8
Issue Information.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 3, p. n/a, doi. 10.1111/1755-5922.12218
- Publication type:
- Article
9
Prevalence of in-hospital nonsteroidal antiinflammatory drug exposure in patients with a primary diagnosis of heart failure.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 3, p. n/a, doi. 10.1111/1755-5922.12256
- By:
- Publication type:
- Article
10
Remote physiological ischemic training promotes coronary angiogenesis via molecular and cellular mobilization after myocardial ischemia.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 3, p. n/a, doi. 10.1111/1755-5922.12257
- By:
- Publication type:
- Article
11
Population-level incidence and monitoring of adverse drug reactions with long-term amiodarone therapy.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 3, p. n/a, doi. 10.1111/1755-5922.12258
- By:
- Publication type:
- Article
12
Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.
- Published in:
- Cardiovascular Therapeutics, 2017, v. 35, n. 3, p. n/a, doi. 10.1111/1755-5922.12259
- By:
- Publication type:
- Article